2023 - Research.com Immunology in United States Leader Award
His primary areas of study are Virology, Coronavirus, Virus, Viral replication and Antibody. Ralph S. Baric studies Virology, focusing on Norovirus in particular. The concepts of his Coronavirus study are interwoven with issues in Interferon, Genome, Middle East respiratory syndrome, Coronaviridae and Innate immune system.
His work in Virus tackles topics such as Molecular biology which are related to areas like RNA-dependent RNA polymerase. His Viral replication course of study focuses on RNA and Exon and DNA. Ralph S. Baric combines subjects such as Viral load and Antigen with his study of Antibody.
His scientific interests lie mostly in Virology, Virus, Coronavirus, Antibody and Viral replication. In his study, Polyclonal antibodies is strongly linked to Monoclonal antibody, which falls under the umbrella field of Virology. His research integrates issues of In vitro and Gene, Virulence in his study of Virus.
His work in Coronavirus addresses issues such as Innate immune system, which are connected to fields such as Interferon. His Antibody study combines topics from a wide range of disciplines, such as Immunity, Antigen and Vaccination. His work in Viral replication addresses subjects such as RNA, which are connected to disciplines such as Molecular biology, Genome and Transcription.
His primary scientific interests are in Virology, Antibody, Virus, Coronavirus and Severe acute respiratory syndrome coronavirus 2. His biological study spans a wide range of topics, including In vitro and In vivo. Ralph S. Baric has included themes like Antigen and Immunity in his Antibody study.
His studies in Virus integrate themes in fields like Pandemic, Disease and Immune system. His work deals with themes such as RNA-dependent RNA polymerase, Chimera, Pneumonia, Receptor and Middle East respiratory syndrome, which intersect with Coronavirus. The various areas that Ralph S. Baric examines in his Severe acute respiratory syndrome coronavirus 2 study include Genome and 2019-20 coronavirus outbreak.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya;Susan C. Baker;Ralph S. Baric;Raoul J. de Groot.
Nature microbiology (2020)
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
Yushun Wan;Jian Shang;Rachel Graham;Ralph S. Baric.
Journal of Virology (2020)
Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking
Mingxun Wang;Jeremy J Carver;Vanessa V Phelan;Laura M Sanchez.
Nature Biotechnology (2016)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
Timothy P. Sheahan;Amy C. Sims;Sarah R. Leist;Alexandra Schäfer.
Nature Communications (2020)
Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group
Alexander E. Gorbalenya;Alexander E. Gorbalenya;Susan C. Baker;Ralph Baric;Raoul J. de Groot.
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan;Amy C. Sims;Rachel L. Graham;Vineet D. Menachery.
Science Translational Medicine (2017)
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.
Raoul J. de Groot;Susan C. Baker;Ralph S. Baric;Caroline S. Brown.
Journal of Virology (2013)
Norwalk Virus: How Infectious Is It?
Peter F.M. Teunis;Christine L. Moe;Pengbo Liu;Sara E. Miller.
Journal of Medical Virology (2008)
Human susceptibility and resistance to Norwalk virus infection
Lisa Lindesmith;Christine Moe;Severine Marionneau;Nathalie Ruvoen.
Nature Medicine (2003)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini;Erica L. Andres;Amy C Sims;Rachel Lauren Graham.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: